No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Join BioAffinity Technologies' Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19
10-Q: Q3 2024 Earnings Report
BioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
BioAffinity Technologies Announces Award of Japanese Patent for CyPath Lung
BioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement
BioAffinity Technologies Announces Secondary Offering of 1.8M Shares